Effect of 3-aminobenzamide on perforation an experimental colitis model
| dc.authorid | Dincel, Aylin Sepici / 0000-0001-5847-0556 | |
| dc.authorwosid | Dincel, Aylin Sepici / N-4321-2019 | |
| dc.contributor.author | Menekse, Ebru | |
| dc.contributor.author | Aydin, Sezai | |
| dc.contributor.author | Dincel, Aylin Sepici | |
| dc.contributor.author | Eroglu, Abdullah | |
| dc.contributor.author | Dolapci, Mete | |
| dc.contributor.author | Yildirim, Osman | |
| dc.contributor.author | Cengiz, Omer | |
| dc.date.accessioned | 2021-11-01T14:58:11Z | |
| dc.date.available | 2021-11-01T14:58:11Z | |
| dc.date.issued | 2014 | |
| dc.department | [Belirlenecek] | |
| dc.description.abstract | Background/Aims: The anti-inflammatory activity of 3-aminobenzamide (3-AB) has been shown via histopathology and immunohistochemistry in various colitis models. We aimed to study the effects of 3-AB on tissue mechanical endurance and, associatively, preventing perforation in colitis. Materials and Methods: Thirty male Wistar albino rats were randomly divided into three groups. Rectal saline was administered to Group 1 (sham + saline). Rectal trinitrobenzensulphonic acid was applied to induce colitis in Group 2 (colitis + saline) and Group 3 (colitis + 3-AB). Groups 1 and 2 were treated intraperitoneally with saline (1 ml every 12 hours) and Group 3 was treated with 3-AB (10 mg/kg every 12 hours). After seven days, rats were sacrificed and colon lipid peroxidation levels, the serum tumor necrosis factor alpha (TNF-alpha) level, bowel bursting pressures, and bowel wall tensions were measured. Results: Bowel bursting pressure in Group 2 was significantly lower than in Groups 1 and 3 (p<0.001 for both groups). Bowel wall tension in Group 2 was significantly lower than in Groups 1 and 3 (p<0.001 for both groups). There were no significant differences between groups for serum TNF-alpha levels. For lipid peroxidation, malondialdehyde (MDA) levels were increased in Groups 2 and 3 compared to Group 1. Conclusion: 3-AB may aid prevention of perforations that develop in inflammatory bowel disease, requiring surgical treatment. | |
| dc.identifier.doi | 10.5152/tjg.2014.4288 | |
| dc.identifier.endpage | 91 | en_US |
| dc.identifier.issn | 2148-5607 | |
| dc.identifier.pmid | 25910375 | |
| dc.identifier.startpage | 86 | en_US |
| dc.identifier.uri | https://doi.org/10.5152/tjg.2014.4288 | |
| dc.identifier.uri | https://hdl.handle.net/11491/6509 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:000353553700017 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.institutionauthor | [Belirlenecek] | |
| dc.language.iso | en | |
| dc.publisher | Aves | |
| dc.relation.ispartof | Turkish Journal Of Gastroenterology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Poly (ADP-ribose) polymerase/synthetase inhibitor | en_US |
| dc.subject | 3-aminobenzamide | en_US |
| dc.subject | colitis | en_US |
| dc.subject | inflammatory bowel disease | en_US |
| dc.title | Effect of 3-aminobenzamide on perforation an experimental colitis model | |
| dc.type | Article |












